Clinical Trial Update: AB8939 in Patients With Relapsed/Refractory Acute Myeloid Leukemia [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial of AB8939 for relapsed or refractory acute myeloid leukemia is currently recruiting. The study also references myelodysplastic syndro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• AB8939

Snippet

Sponsor: AB Science | Conditions: Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse | Phase 1, Phase 2 | Status: RECRUITING